KHB(SZ:002022) Mei Ri Jing Ji Xin Wen·2025-08-13 15:47Core Viewpoint - The establishment of a new wholly-owned subsidiary, Shenzhen Kehua Weijian Technology Co., Ltd., by Kehua Bio (002022.SZ) aims to align with the company's strategic development, focusing on the in vitro diagnostics industry while exploring potential collaborations in artificial intelligence and robotics [2]. Group 1 - Kehua Bio announced the establishment of Shenzhen Kehua Weijian Technology Co., Ltd. on August 5, 2025, to support its development strategy [2]. - The company has been deeply involved in the in vitro diagnostics industry for many years and has not yet engaged in artificial intelligence or robotics research and development [2]. - Kehua Bio is enhancing its external technical cooperation by collaborating with universities, research institutions, and innovation centers to create an open innovation platform [2].